Business Model (A)

IDRS identifies various products and progresses along the development path to create substantial value in the product. The products are licensed to partners for commercialization.

Business Model (B)

Project Overlook

In this model, IDRS has successfully out-licensed all developed projects. Many of the top 10 pharmaceutical companies are our partners for these projects. The projects in pipeline are in early development stages
COVID Update
Team IDRS is committed towards working on complex products in niche therapeutic areas to address the unmet medical needs. This extends to the current challenging time, where the entire scientific community is working towards bringing some therapeutic option to provide relief from Covid-19 and associated complications. Our team, in collaboration with some of the premier Indian Institutes, is fervently working on a phytopharmaceutical product that will not only provide an option to treat Covid 19 patients but also minimise post Covid complications. Watch this space for further updates.